HPV and Cervical Cancer: Updates on an Established Relationship

@article{Subramanya2008HPVAC,
  title={HPV and Cervical Cancer: Updates on an Established Relationship},
  author={D. Subramanya and P. Grivas},
  journal={Postgraduate Medicine},
  year={2008},
  volume={120},
  pages={13 - 7}
}
Abstract Despite cervical cancer being considered a preventable disease, it still remains the second most common malignancy in women worldwide, with a higher incidence in underdeveloped countries. Human papillomavirus (HPV) is considered the causative agent of cervical cancer. The major mechanisms through which HPV contributes to neoplastic initiation and progression include the activity of 2 viral oncoproteins, E6 and E7, which interfere with critical cell cycle tumor suppressive proteins, p53… Expand
Human Papillomavirus DNA Testing: What, How, and When
TLDR
The development of a preventive vaccine, the current versions of which appear to prevent close to 100% of persistent genital infection and disease caused by HPV-16 and HPV-18, may have a major impact on approaches to reduce the incidence of this disease. Expand
Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
TLDR
The close links between HIV and HPV justify linking cervical cancer prevention, screening, and management programs with AIDS programs as part of the " 90-90-90" initiative of the UNAIDS, both nationally and regionally. Expand
Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease
TLDR
The main issues discussed here are related to the public health burden of cervical cancer in sub-Saharan Africa and predictions for the coming decades, including molecular epidemiology and determinants of HPV infection in Africa, and promising prevention measures currently being evaluated in Africa. Expand
The Prognostic Role of Human Papillomavirus in Patients With Vaginal Cancer
TLDR
Human papillomavirus infection was frequently detected in squamous cell carcinoma of the vagina, and its presence may serve as a prognostic indicator in advanced stages. Expand
From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
TLDR
Despite the limited number of studies investigating circulating miRNAs in distinct biological fluids, accumulating data have pointed some promising candidates, both as cell-free or EV-derivedMiRNAs, and bring attention to the urgent need for efforts in this field. Expand
The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population
TLDR
The KIR genes were not associated with HPV, although some pairs of i(inhibitory)KIR-ligands occurred more frequently in patients, supporting a role for NK in detrimental chronic inflammatory and carcinogenesis. Expand
Novel Biomarkers in the Management of HPV-Positive & -Negative Oropharyngeal Carcinoma
TLDR
Comparison of HPV-positive and -negative oropharyngeal carcinoma offers unprecedented insight into the biological significance of each aetiological agent, and how prognostication of each disease may relate to tumour behaviour at a molecular level. Expand
Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo
TLDR
This study showed the diversity of circulating HPV genotypes in Togo and programs of HPV vaccination and early detection of benign or precancerous lesions should be implemented to reduce cancer-related comorbidities. Expand
At the center of cervical carcinogenesis: synergism between high-risk HPV and the hyperactivated YAP1
TLDR
It is found that synergism between hyperactivated YAP1 and high-risk HPV is a key driver of cervical cancer initiation and progression. Expand
HPV and Cancer
TLDR
Most infections with high-risk HPVs do not cause cancer, but infections that last for many years increase a person’s risk of developing cancer. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 67 REFERENCES
[Hpv cofactors in cervical carcinogenesis].
TLDR
Possible co-factors of HPV in the genesis of the squamous carcinoma of uterine cervix are discussed, taking into account only the factors whose association with the virus or cervical cancer has been documented by experimental studies, and not based just on clinical or epidemiological data. Expand
Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.
TLDR
HPV integration in the genome will lead to inactivation of the p53 pathway and the Rb pathway, essential for the onset of cervical carcinogenesis, but probably not sufficient for progression to invasive cervical cancers. Expand
[Epidemiology of cervical papillomavirus infections. Recent knowledge].
TLDR
While waiting for clinically applicable vaccination programs, strategies to prevent cervical cancer include improved screening covering the widest possible population and using HPV testing, 2) close management and follow-up of women with precancerous lesions. Expand
Co-fatores do HPV na oncogênese cervical
TLDR
Possible co-factors of HPV in the genesis of the squamous carcinoma of uterine cervix are discussed, taking into account only the factors whose association with the virus or cervical cancer has been documented by experimental studies, and not based just on clinical or epidemiological data. Expand
Papillomavirus vaccines in clinical trials.
TLDR
A firm grasp of the molecular pathogenesis of HPVs and the natural history of genital HPV infections, combined with greater understanding of how to trigger effective immune responses, offers hope for the elimination of HPV-associated diseases. Expand
Human papillomavirus: epidemiology and public health.
TLDR
Clinicians and patients will need to shift discussions of the mildly abnormal Papanicolaou test to consideration of HPV infection as a common sexually transmitted infection that rarely causes cervical cancer. Expand
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
TLDR
Across the spectrum of cervical lesions, HPV-16 is consistently the most common HPV type contributing to 50-55% of invasive cervical cancer cases strongly suggesting that this viral type has a biological advantage for transmission, persistency and transformation. Expand
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
TLDR
The greater sensitivity of HPV DNA testing compared to cytology argues strongly for using HPVDNA testing as the primary screening test in newly implemented programmes, except where resources are extremely limited and only programmes based on visual inspection are affordable. Expand
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
TLDR
The data show that the great majority of all grades of CIN can be attributed to HPV infection, particularly with the cancer-associated types of HPV. Expand
Epidemiologic classification of human papillomavirus types associated with cervical cancer.
TLDR
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic. Expand
...
1
2
3
4
5
...